Overexpression of MACC1 and the association with hepatocyte growth factor/c-Met in epithelial ovarian cancer

Oncology Letters

Volumn 9, Issue 5, 2015, Pages 1989-1996

  Li, Hongyu ^a   Zhang, Hui ^a   Zhao, Shujun ^a   Shi, Yun ^a   Yao, Junge ^a   Zhang, Yanyan ^a   Guo, Huanhuan ^a   Liu, Xingsuo ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

c Met; ELISA; Epithelial ovarian tumors; HGF; IHC; MACC1; RT PCR

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; PEPTIDES AND PROTEINS; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET SPECTROPHOTOMETRY; UPREGULATION;

EID: 84925438053     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.2984     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277‑300, 2010.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74‑108, 2005.
3. Gu M and Shi W: Current Research Management of Ovarian Cancer in China. The Chinese German Journal of Clinical Oncology 4: 212-218, 2002.
4. Shen K: The progress and challenge of chemotherapy in ovarian cancer. Chin J Clin Obstet Gynecol 2002: 3‑7, 2002.
5. Qiu J, Huang P, Liu Q, et al: Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9: 166, 2011.
6. Ponzo MG, Lesurf R, Petkiewicz S, et al: Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci USA106: 12903‑12908, 2009.
7. Cappuzzo F, Marchetti A, Skokan M, et al: Increased MET gene copy number negatively affects survival of surgically resected non‑small‑cell lung cancer patients. J Clin Oncol 27: 1667‑1674, 2009.
8. Stein U, Dahlmann M and Walther W: MACC1‑more than metastasis? Facts and predictions about a novel gene. J Mol Med (Berl) 88: 11‑18, 2010.
9. Regauer S and Reich O: CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from highgrade cervical intraepithelial neoplasia (CINIII). Histopathology 50: 629-635, 2007.
10. Boardman LA: Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1: 36, 2009.
11. Liang P and Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967‑971, 1992.
12. Stein U, Walther W, Arlt F, et al: MACC1, a newly identified key regulator of HGF‑MET signaling, predicts colon cancer metastasis. Nat Med 15: 59‑67, 2009.
13. Chundong G, Uramoto H, Onitsuka T, et al: Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 31: 1141‑1145, 2011.
14. Stein U, Smith J, Walther W and Arlt F: M ACC 1 controls Met ‑ what a difference an Sp1 site makes. Cell Cycle 8: 2467‑2469, 2009.
15. Birchmeier C, Birchmeier W, Gherardi E and Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915‑925, 2003.
16. Arlt F and Stein U: Colon cancer metastasis: MACC 1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41: 2356g‑2359g, 2009.
17. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ: Isolation of biologically active ribonucleic acid from sourses enriched in ribonuclease. Biochemistry 18: 5294‑5299, 1979.
18. Ferracini R, Di Renzo MF, Scotlandi K, et al: The Met/HGF receptor is over‑expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10: 739‑749, 1995.
19. Schmittgen TD and Livak KJ: Analyzing real‑time PCR data by the comparative C(T) method. Nat Protoc 3: 1101‑1108, 2008.
20. Huntsman D, Resau JH, Klineberg E and Auersperg N : Comparison of c‑met expression in epithelial ovarian tumors and normal epithelial of the female reproductive extract by quantitative laser scan microscopy. Am J Pathol 155: 343‑348, 1999.
21. Maggiora P, Lorenzato A, Fracchioli S, et al : The RON and MET oncogenes are co‑expressed in human ovarian car cinemas and cooperate in activating invasiveness. Exp Cell Res 288: 382‑389, 2003.
22. Sattler M and Salgia R : c‑Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 9: 102‑108, 2007.
23. Bottaro DP, Rubin JS, Faletto DL, et al: Identification of the hepatocyte growth factor receptor as the c‑met proto‑oncogene product. Science 251: 802‑804, 1991.
24. Chmielowiec J, Borowiak M, Morkel M, et al : c‑Met is essential for wound healing in the skin. J Cell Biol 177: 151‑162, 2007.
25. Kaposi‑NovakP,Lee JS, Gòmez‑Quiroz L, et al : Met‑regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 116: 1582‑1595, 2006.
26. Shirahata A, Sakata M, Kitamura Y, et al: MACC 1 as a marker for peritoneal‑disseminated gastric carcinoma. Anticancer Res 30: 3441‑3444, 2010.
27. Shirahata A, Fan W, Sakuraba K, et al: MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 31: 777‑780, 2011.